Clinical Trials Prostate Cancer Treated with Prostatectomy or Radiation
This Information is provided to help patients identify clinical trials for educational purposes and not to recruit patients for any specific trials. Patients should consult with their personal doctor and the trial sponsors for additional information on trials of interest.
Study of the use of targeted therapy to improve quality of life for participants who have undergone radical prostatectomy
Study of a DNA vaccine and Nivolumab in Patients With Non-Metastatic Recurrent Prostate Cancer
Number: NCT03600350 PHEN Patient Summary ClinicalTrials.gov Information Trial Phase: Phase 2 Sponsor(s): University of Wisconsin, Madison|National Cancer Institute (NCI)|Bristol-Myers Squibb|Madison Vaccines Inc. (MVI) Sponsor Trial Information Trial Location(s) and Contact(s)
Fluciclovine F18 or Ga68-PSMA PET/CT to Enhance Prostate Cancer Outcomes